RTTNews | Jan 26, 2022 10:54AM EST

10:53 Wednesday, January 26, 2022 (RTTNews.com) - Shares of Mainz Biomed B.V. (MYNZ) tanked over 25% on Wednesday morning. The company announced that it priced a follow-on offering at $15 per share.

MYNZ is currently trading at $15.00, down $5.25 or 25.93%, on the Nasdaq.

Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer, announced the pricing of its underwritten public follow-on offering of 1.5 million ordinary shares at a price of $15.00 per share for gross proceeds of $22.5 million.

Read the original article on RTTNews ( https://www.rttnews.com/3257461/mainz-biomed-stock-down-25-as-it-prices-offering-at-15-shr.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2022 RTTNews.com All Rights Reserved